Trials / Completed
CompletedNCT00810004
Maintenance Treatment of Iron Deficiency in IBD Patients
A Multi-centre, Randomised, Prospective, Single-blinded, Controlled Study to Investigate the Efficacy and Safety of a Standardised Maintenance Dosage Regimen of Intravenous Ferric Carboxymaltose (FERINJECT®) Versus Placebo in Patients With Iron Deficiency Caused by Inflammatory Bowel Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 245 (actual)
- Sponsor
- Vifor Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the treatment of iron deficiency in IBD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferinject | Intravenous infusion of iron |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2008-12-17
- Last updated
- 2012-12-21
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT00810004. Inclusion in this directory is not an endorsement.